- Integer Holdings Corporation has appointed Payman Khales as President and Chief Executive Officer, effective as part of a planned transition announced in April 2025.
- Former CEO Joseph Dziedzic will retire after eight years in the role and continue as an advisor through March 2026.
Integer Holdings Corporation, a global medical device contract development and manufacturing organisation (CDMO), has confirmed that Payman Khales has assumed the role of President and Chief Executive Officer. The appointment follows a planned leadership transition first announced in April 2025.
Khales, who also joins the company’s Board of Directors, succeeds Joseph Dziedzic, who is retiring after eight years as President and CEO. Dziedzic will remain with Integer as an advisor until March 31, 2026, to ensure a smooth transition.
Since joining Integer in 2018 as President of the Cardio & Vascular business, Khales has led a strategy focused on market growth and customer engagement. During his tenure, sales doubled over seven years, with improved profitability and service performance. Most recently, as Chief Operating Officer, he oversaw both of Integer’s business units and its global operations.
“It is a privilege to step into the role of CEO at Integer,” said Khales. “I am energized by the opportunities ahead as we continue to advance our strategy. Together with our talented associates, we will create value by innovating, collaborating with our customers, and delivering life-changing medical technologies to patients around the world.”
Prior to joining Integer, Khales held leadership positions at CECO Environmental Corp. and Ingersoll Rand Company. He holds an Executive MBA from Indiana University’s Kelley School of Business and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal.
